A falsifiable flat rate against a thin file: the comparison that’s really about what a shopper can verify today.
The two models
Henry Meds advertises the market’s best-known flat-rate compounded pricing — a structure we favor on principle, because flat rates make teaser math impossible. Whether the advertised flat number survives contact with membership terms, shipping, and dose realities is precisely what its pending verification pass will establish; until then, no Henry figure is published here.
Shed is a marketing-forward entrant whose public materials leave the load-bearing questions — which pharmacies compound, what the maintenance-dose total runs, what the membership terms bind — thinly documented. That thinness is a data point, not a verdict; verification is queued, and no Shed figures are repeated here.
Verified vs pending — read this before the marketing
Neither provider on this page has completed price verification, so this comparison stays structural — business models, pricing architecture, and the questions each must answer — with zero advertised numbers repeated as facts. The only verified figures on this site today sit in the ledger.
Auditability as the tiebreaker
Strip the branding and this pairing asks one question: which claim can you test this afternoon? Henry’s flat number invites the calculator’s 12-month stress test and a terms-page read; Shed’s materials mostly invite more questions. Our verification will eventually score both on results; until then, the shopper’s edge goes to whichever provider answers the documentation requests faster and in writing — a race any provider can win by simply publishing more.
Go deeper
Full files: Henry Meds · Shed. Decision tools: the quiz routes by coverage and priorities; the calculator turns any quote into a true 12-month number; the ledger holds every verified figure and every pending slot.